Journal ArticleOPEN ACCESS

Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy

Cancer (1984) 54(4) 744-750
DOI: 10.1002/1097-0142(1984)54:4<744::AID-CNCR2820540426>3.0.CO;2-P
138Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Seventy‐two patients with advanced prostatic carcinoma without previous endocrine therapy were treated with an oral nonsteroidal antiandrogen, flutamide. Sixty‐three patients (87.5%) had a favorable response, and 9 patients showed no response. Flutamide appears to be a safe antiandrogen, usually effective in the management of patients with advanced prostatic cancer who have had no prior endocrine therapy. Copyright © 1984 American Cancer Society

Cite

CITATION STYLE

APA

Sogani, P. C., Vagaiwala, M. R., & Whitmore, W. F. (1984). Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy. Cancer, 54(4), 744–750. https://doi.org/10.1002/1097-0142(1984)54:4<744::AID-CNCR2820540426>3.0.CO;2-P

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free